Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cabot (CBT) Gains from Sales and Divestitures (2022 - 2025)

Cabot (CBT) has disclosed Gains from Sales and Divestitures for 15 consecutive years, with $292000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Gains from Sales and Divestitures fell 38.91% to $292000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $292000.0, a 38.91% decrease, with the full-year FY2025 number at $292000.0, down 38.91% from a year prior.
  • Gains from Sales and Divestitures was $292000.0 for Q3 2025 at Cabot, down from $478000.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $478000.0 in Q3 2024 to a low of $184000.0 in Q3 2021.
  • A 5-year average of $288400.0 and a median of $275000.0 in 2023 define the central range for Gains from Sales and Divestitures.
  • Peak YoY movement for Gains from Sales and Divestitures: skyrocketed 73.82% in 2024, then crashed 38.91% in 2025.
  • Cabot's Gains from Sales and Divestitures stood at $184000.0 in 2021, then grew by 15.76% to $213000.0 in 2022, then grew by 29.11% to $275000.0 in 2023, then soared by 73.82% to $478000.0 in 2024, then crashed by 38.91% to $292000.0 in 2025.
  • Per Business Quant, the three most recent readings for CBT's Gains from Sales and Divestitures are $292000.0 (Q3 2025), $478000.0 (Q3 2024), and $275000.0 (Q3 2023).